Adenosine A2a Receptor-Mediated Neuroinflammation in Remote Ischemic Conditioning for Post-Stroke Sleep Disorders

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 136 participants.

Also called NCT07874594

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 136 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07874594
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07874594. Randomized; double masking; primary purpose treatment. Start 2026-09-01 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Adenosine A2a Receptor-Mediated Neuroinflammation in Remote Ischemic Conditioning for Post-Stroke Sleep Disorders
Acronym
RIC-A2AR-SD
Condition
Insomnia
Condition
Sleep Wake Disorders
Intervention (Device)
RIC Intervention Group
Intervention (Device)
Sham Control Group
Lead sponsor
Sichuan Academy of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct07874594
Content hash
36fdfc92f2e5af4106533e079b5e7affd3ae1e0d1b08b2f03451649197101446